Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.
Stefan Müller-Lissner, Gabrio Bassotti, Benoit Coffin...
https://pubmed.ncbi.nlm.nih.gov/28034973/Actively Recruiting
Led by Konya City Hospital · Updated on 2025-09-23
106
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the effects of two opioids, fentanyl and remifentanil, on bowel recovery and pain after laparoscopic gallbladder surgery. Postoperative ileus, a delay in bowel function, is a common problem after abdominal surgery and can lead to longer hospital stays and increased costs. This trial aims to compare how these two drugs impact the time it takes for bowel function to return and how patients manage pain after surgery. Participants will be randomly assigned to receive either fentanyl or remifentanil during their surgery. Those in the fentanyl group will get an initial intravenous dose of 2 micrograms per kilogram followed by a continuous infusion of 1 to 2 micrograms per kilogram per hour. Those in the remifentanil group will receive a 1 microgram per kilogram IV dose followed by a continuous infusion of 0.1 to 1 microgram per kilogram per minute. Standard anesthesia drugs, including propofol, rocuronium, and sevoflurane, will be used for all patients. During the study, researchers will monitor the time until the first passage of gas as the main measure of bowel recovery, along with time to first bowel movement, ability to tolerate food, pain levels, need for additional pain medication, nausea and vomiting, stay times in recovery and hospital, and patient satisfaction. These outcomes will be tracked up to several days after surgery. The study includes 106 adults aged 18 to 65 who are healthy enough for elective surgery and will last through hospital discharge and follow-up assessments.
CONDITIONS
Fentanyl vs. Remifentanil in Laparoscopic Cholecystectomy: Effects on Bowel Function and Pain
M
MUSTAFA BÜYÜKCAVLAK, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Konya City Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 hours (duration of surgery and anesthesia)
Participants receive either fentanyl or remifentanil during anesthesia for laparoscopic cholecystectomy.
1 surgical and anesthesia visit
Duration - Up to 7 days postoperatively
Participants are monitored for bowel function recovery and postoperative pain after surgery.
Daily visits or assessments for up to 7 days
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Stefan Müller-Lissner, Gabrio Bassotti, Benoit Coffin...
https://pubmed.ncbi.nlm.nih.gov/28034973/Hans Donald de Boer, Olivier Detriche, Patrice Forget
https://pubmed.ncbi.nlm.nih.gov/29739538/Ryash Vather, Sid Trivedi, Ian Bissett
https://pubmed.ncbi.nlm.nih.gov/23377782/Sebastian Niedermayer, Jens Heyn, Felix Guenther...
https://pubmed.ncbi.nlm.nih.gov/31592999/Konya City Hospital
Lead Sponsor